Denmark – Pharmaceutical products – Amgros 2027 2.206.a

Opportunity description

Amgros I/S (Amgros) is a partnership with the 5 regions as partners. Amgros wishes to enter into framework agreements for the medicinal products listed in the individual lots below, with a view to supplying the partners’ hospital pharmacies with medicinal products and possible resale to the Faroe Islands and Greenland. Amgros resells the medicinal products to the hospital pharmacies at Amgros’ purchase price plus a surcharge. The framework agreements are non-exclusive. The framework agreements are entered into without any purchase obligation, and the hospital pharmacies in the regions are not obliged to use Amgros’ framework agreements. The procurement number (lot) comprises the following medicinal products: ATC Code: H01BB02 · Generic name: Oxytocin · Pharmaceutical form: Concentrate for solution for injection/infusion · Strength: 5 IU/ml · Unit value: 15 U · Quantity in units: 999. Each procurement number is regarded as a separate lot and is tendered independently of the other procurement numbers. A supplier may therefore choose to submit a tender for one, several or all procurement numbers, and awards are made separately for each individual procurement number. A supplier may therefore be awarded one, several or all lots. Reference is made to the procurement conditions, including regarding the submission of tenders under the individual procurement numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the procurement number is stated, but actual consumption may deviate significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the procurement conditions and the framework agreement. The procurement number (lot) comprises the following medicinal products: ATC Code: H01BB02 · Generic name: Oxytocin · Pharmaceutical form: Concentrate for solution for injection/infusion · Strength: 10 IU/ml · Unit value: 15 U · Quantity in units: 106526. Each procurement number is regarded as a separate lot and is tendered independently of the other procurement numbers. A supplier may therefore choose to submit a tender for one, several or all procurement numbers, and awards are made separately for each individual procurement number. A supplier may therefore be awarded one, several or all lots. Reference is made to the procurement conditions, including regarding the submission of tenders under the individual procurement numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the procurement number is stated, but actual consumption may deviate significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the procurement conditions and the framework agreement. The procurement number (lot) comprises the following medicinal products: ATC Code: H02AB08 · Generic name: Triamcinolone · Pharmaceutical form: Solution for injection · Strength: 20 mg/ml · Pack: 1-20 pcs · Unit value: 7.5 mg · Quantity in units: 7574. Each procurement number is regarded as a separate lot and is tendered independently of the other procurement numbers. A supplier may therefore choose to submit a tender for one, several or all procurement numbers, and awards are made separately for each individual procurement number. A supplier may therefore be awarded one, several or all lots. Reference is made to the procurement conditions, including regarding the submission of tenders under the individual procurement numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the procurement number is stated, but actual consumption may deviate significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the procurement conditions and the framework agreement. The procurement number (lot) comprises the following medicinal products: ATC Code: H02AB08 · Generic name: Triamcinolone · Pharmaceutical form: Solution for injection · Strength: 20 mg/ml · Pack: 21-50 pcs · Unit value: 7.5 mg · Quantity in units: 8400. Each procurement number is regarded as a separate lot and is tendered independently of the other procurement numbers. A supplier may therefore choose to submit a tender for one, several or all procurement numbers, and awards are made separately for each individual procurement number. A supplier may therefore be awarded one, several or all lots. Reference is made to the procurement conditions, including regarding the submission of tenders under the individual procurement numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the procurement number is stated, but actual consumption may deviate significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the procurement conditions and the framework agreement. The procurement number (lot) comprises the following medicinal products: ATC Code: H02AB08 · Generic name: Triamcinolone · Pharmaceutical form: Solution for injection · Strength: 40 mg/ml · Unit value: 7.5 mg · Quantity in units: 208106. Each procurement number is regarded as a separate lot and is tendered independently of the other procurement numbers. A supplier may therefore choose to submit a tender for one, several or all procurement numbers, and awards are made separately for each individual procurement number. A supplier may therefore be awarded one, several or all lots. Reference is made to the procurement conditions, including regarding the submission of tenders under the individual procurement numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the procurement number is stated, but actual consumption may deviate significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the procurement conditions and the framework agreement. The procurement number (lot) comprises the following medicinal products: ATC Code: H03AA01 · Generic name: Levothyroxine sodium · Pharmaceutical form: Solution for injection and infusion · Strength: 200 micrograms/ml · Unit value: 0.15 mg · Quantity in units: 480. Each procurement number is regarded as a separate lot and is tendered independently of the other procurement numbers. A supplier may therefore choose to submit a tender for one, several or all procurement numbers, and awards are made separately for each individual procurement number. A supplier may therefore be awarded one, several or all lots. Reference is made to the procurement conditions, including regarding the submission of tenders under the individual procurement numbers. Under the designation "quantity in units" above, an estimated consumption of the medicinal products under the procurement number is stated, but actual consumption may deviate significantly from this. Suppliers must take this into account. The reason for this is that these are medicinal products for patient treatment at public hospitals, where the patient’s needs must be met. For a more detailed description, reference is made to the procurement conditions and the framework agreement. Procedure: open. Estimated value: 49,700,000 DKK. Review the original TED notice for the complete requirement, lots, amendments and attachments.